tirzepatide vs semaglutide effects caused roughly half as many patients to stop treatment because of gastrointestinal side as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs Semaglutide | Heal

These are most common during the dose-escalation phase and tend to improve as the body adjusts to the medicine

The systemic nature of PCOS demands a paradigm shift toward integrated, multidisciplinary management, treating the patient as a metabolic whole

Zwickler, T., Lindner, M., Aydin, H

The peptide seems to impact nitric oxide pathways, which regulate vessel tone and tissue oxygenation, critical for a properly perfused endometrium during the implantation window

While DTC models may improve access and shift employer prescription costs, theres no evidence that they will solve the obesity burden or reduce total healthcare costs long-term

Right now, CVS is in the spotlight, but Gelfand is worried this kind of policy could spread to other drugs or payers